Global Bioprocessing Equipment Market: Size, Trends & Forecasts (2021-2025 Edition)
- Report Description Table of Contents
Scope of the Report
The report titled “Global Bioprocessing Equipment Market: Size, Trends & Forecasts (2021-2025 Edition)”, provides an in depth analysis of the global bioprocessing equipment market by value, bioprocessing capacity and segments.
The report also includes a detailed analysis of SUT bioprocessing equipments market for the regions of North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. Under competitive landscape, different players in the global bioprocessing equipment market have been compared on the basis of share.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global bioprocessing equipment market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Sartorius, Merck KGaA, Danaher, General Electric Company (GE Healthcare) and ThomsonFisher Scientific are some of the major players operating in the market whose company profiling has been done in the report. In this section of the report, business overview, financial overview and business strategies of the companies have been included.
- Merck KGaA
- General Electric Company (GE Healthcare)
- ThomsonFisher Scientific
- North America
- Latin America
- Asia Pacific
- Middle East and Africa
Bioprocessing equipment (or biopharmaceutical manufacturing equipment) market encompasses a broad spectrum of equipments for specific functions and applications. It can be divided on the basis of process steps into upstream and downstream. On the basis of product type, the market can bio processors, disposable filter cartridges, depth filters, tangential flow filtration devices etc. On the basis of application, the market can be split into Monoclonal Antibodies, Vaccines, Recombinant Proteins etc. In-house biopharmaceutical companies, contract manufacturing organization, R and D companies and academic institutes are the end users of these equipments. Single use (SUT) and stainless steel is the segmentation of the market according to technology.
The global bioprocessing equipment market is forecasted to grow at a healthy rate during the forecast period on the account of various growth drivers such as rising prevalence of chronic diseases, rising spending on healthcare and elevation in the number of approvals of biologics. The players in the bioprocessing equipment market are confronted with challenge to keep their revenue inflow uninterrupted in the event of equipment malfunctioning. Also, stringent FDA inspection mechanism puts the operations of pharma companies at uncertain closure risks which in turn poses a threat of loosing clients for bioprocessing equipment manufacturers.
Increasing adoption of SUT bioprocessing equipments, scope of continuous bioprocessing (CBP), spike in acquisition activity and technological innovations are some of the latest trends existing in the market.